Friday, 7 July, 2023

PharmEasy, Indian Unicorn, Faces Deep Crisis with Significant Valuation Cut

PharmEasy, a prominent Indian unicorn in the healthcare sector, is currently grappling with a severe crisis as its valuation undergoes a substantial reduction. The company, which offers online medicine delivery services, is facing challenges that have resulted in a sharp decline in its valuation. This crisis has raised concerns about the company's future prospects and its ability to overcome the hurdles it currently faces. The situation highlights the complexities in healthcare industry.